HPP

PJSC RusHydro: RusHydro Group announces 9M 2021 IFRS results

Thursday, November 25, 2021 - 12:06pm

In 9M 2021, the Group's net profit decreased by 13.3% to RUB 52,443 mn following absence of significant revaluations of the forward contract on the company's shares which was accounted for in 9M 2020.

Key Points: 
  • In 9M 2021, the Group's net profit decreased by 13.3% to RUB 52,443 mn following absence of significant revaluations of the forward contract on the company's shares which was accounted for in 9M 2020.
  • RusHydro Group began construction of 23.4 MW Cherekskaya small HPP (earlier Psygansu small HPP) in Kabardino-Balkarian Republic.
  • *****The Boguchanskaya hydropower plant is part of the Boguchanskiy Energy and Metals Complex (BEMO), a joint venture (JV) between RusHydro and UC RUSAL, and is not part of RusHydro Group.
  • RusHydro Group is the leading producer of renewable energy in Russia with over 400 generating facilities.

Griffin Hoffmann Joins Hill Property Partners as Partner; Plans to Expand Investment Platform

Wednesday, November 17, 2021 - 6:08pm

NEW YORK, Nov. 17, 2021 (GLOBE NEWSWIRE) -- New York-based Hill Property Partners (HPP) announces that Griffin Hoffmann has joined the private investment firm as Partner.

Key Points: 
  • NEW YORK, Nov. 17, 2021 (GLOBE NEWSWIRE) -- New York-based Hill Property Partners (HPP) announces that Griffin Hoffmann has joined the private investment firm as Partner.
  • Hoffmann, who most recently served as Head of Acquisitions and Development at Somerset Partners, will work alongside the companys founder, Mitchel Hill, to expand and grow HPPs new investment platform.
  • Griffin brings more than 11 years of direct real estate investing experience to his position at HPP.
  • I am extremely excited to join Mitch and look forward to growing HPPs existing portfolio and platform, said Hoffmann.

Hiperbaric's Anthony Zapata Earns PMMI On the Rise Award

Friday, November 19, 2021 - 6:00pm

MIAMI, Nov. 19, 2021 /PRNewswire-PRWeb/ -- PMMI, The Association for Packaging and Processing Technologies, has named Anthony Zapata , Marketing & Sales Specialist for Hiperbaric, a 2021 On the Rise Award winner.

Key Points: 
  • MIAMI, Nov. 19, 2021 /PRNewswire-PRWeb/ -- PMMI, The Association for Packaging and Processing Technologies, has named Anthony Zapata , Marketing & Sales Specialist for Hiperbaric, a 2021 On the Rise Award winner.
  • Zapata has enhanced Hiberbaric's sales operations, data analysis and lead management practices.
  • Zapata took the company's marketing initiatives to new heights by building a professional marketing infrastructure, positioning Hiperbaric as the global leader in the HPP industry.
  • Since day one, Anthony has shown initiative and dedication to move Hiperbaric forward as a company," said Roberto Peregrina, director, Hiperbaric USA.

Feel Foods Extends Shelf Life of Its Black Sheep Vegan Cheeze Products Using All-Natural HPP Process

Tuesday, November 16, 2021 - 8:01am

Convenience and savings are also associated with a longer shelf life.

Key Points: 
  • Convenience and savings are also associated with a longer shelf life.
  • HPP does not include chemicals or heat and maintains the natural freshness and flavours whilst extending the shelf life of your products.
  • High Pressure Processing (HPP) is a cold pasteurization technique by which food products are exposed to extremely high pressure (300-600MPa / 43,500-87,000psi) transmitted by water.
  • Feel Foods wholly owned premium vegan cheese brand Black Sheep Vegan Cheeze (Black Sheep) was founded in 2017 and is currently producing variety of unique vegan dairy substitute products at the Companys Okanagan commercial kitchen and R&D facility.

Nordic Nanovector supports The Health Policy Partnership's initiative to improve appropriate readiness for radioligand therapy (radioimmunotherapy) in lymphoma

Tuesday, November 9, 2021 - 5:20pm

OSLO, Norway, Nov. 9, 2021 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) a clinical-stage biotechnology company dedicated to extending and improving the lives of patients with haematological cancers, is supporting an independent government affairs project led by The Health Policy Partnership (HPP), a specialist health policy research organisation. Within this project, an international framework (the Radioligand Therapy Readiness Assessment Framework) has been assembled to assess health system readiness for the use of radioligand therapy and to identify policy changes that could facilitate appropriate integration of this innovative cancer treatment modality. The framework can be adapted to any country or health service context, and HPP has worked with experts to apply the framework initially to the US and UK health systems.

Key Points: 
  • Within this project, aninternational framework (the Radioligand Therapy Readiness Assessment Framework) has been assembled to assess health system readiness for the use of radioligand therapy and to identify policy changes that could facilitate appropriate integration of this innovative cancer treatment modality.
  • The framework can be adapted to any country or health service context, and HPP has worked with experts to apply the framework initially to the US and UK health systems.
  • Because radioligand therapy is highly targeted to cancer cells, healthy cells are left largely unaffected, reducing treatment side effects and improving their tolerability1.
  • The framework has been applied to the US and UK health systems with guidance from national expert advisory groups.

Nordic Nanovector supports The Health Policy Partnership's initiative to improve appropriate readiness for radioligand therapy (radioimmunotherapy) in lymphoma

Tuesday, November 9, 2021 - 5:18pm

Within this project, aninternational framework (the Radioligand Therapy Readiness Assessment Framework) has been assembled to assess health system readiness for the use of radioligand therapy and to identify policy changes that could facilitate appropriate integration of this innovative cancer treatment modality.

Key Points: 
  • Within this project, aninternational framework (the Radioligand Therapy Readiness Assessment Framework) has been assembled to assess health system readiness for the use of radioligand therapy and to identify policy changes that could facilitate appropriate integration of this innovative cancer treatment modality.
  • The framework can be adapted to any country or health service context, and HPP has worked with experts to apply the framework initially to the US and UK health systems.
  • Because radioligand therapy is highly targeted to cancer cells, healthy cells are left largely unaffected, reducing treatment side effects and improving their tolerability1.
  • The framework has been applied to the US and UK health systems with guidance from national expert advisory groups.

Hudson Pacific Properties Announces Pricing of Preferred Stock Offering

Friday, November 5, 2021 - 12:56am

Hudson Pacific Properties, Inc. (the Company or Hudson Pacific) (NYSE: HPP) today announced the pricing of an underwritten public offering of 16,000,000 shares of 4.750% Series C Cumulative Redeemable Preferred Stock, at a price per share of $25.00, for gross proceeds of $400,000,000, before deducting the underwriting discount and estimated offering expenses.

Key Points: 
  • Hudson Pacific Properties, Inc. (the Company or Hudson Pacific) (NYSE: HPP) today announced the pricing of an underwritten public offering of 16,000,000 shares of 4.750% Series C Cumulative Redeemable Preferred Stock, at a price per share of $25.00, for gross proceeds of $400,000,000, before deducting the underwriting discount and estimated offering expenses.
  • The Company has granted the underwriters of the offering a thirty day option to purchase up to 2,400,000 additional shares of 4.750% Series C Cumulative Redeemable Preferred Stock solely to cover over-allotments, if any.
  • BofA Securities, Morgan Stanley, Wells Fargo Securities and RBC Capital Markets are acting as joint book-running managers for the offering.
  • Hudson Pacific is a real estate investment trust with a portfolio of office and studio properties totaling over 20 million square feet, including land for development.

U.S. High-End Liquid Refreshment Beverages Market Report: How Premiumization Trends have Affected the LRB Market - ResearchAndMarkets.com

Thursday, November 4, 2021 - 10:59am

The "High-End Liquid Refreshment Beverages in the U.S." report from Beverage Marketing has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "High-End Liquid Refreshment Beverages in the U.S." report from Beverage Marketing has been added to ResearchAndMarkets.com's offering.
  • High-End Liquid Refreshment Beverages in the U.S. charts how the premiumization trends has affected the various components of the liquid refreshment beverage (LRB) market.
  • This report from Beverage Marketing Corporation considers the high-end segments of bottled water, energy drinks, carbonated soft drinks (CSDs) and more.
  • How do high-end energy drinks differ from standard ones, and how has this affected the overall category's performance.

Aruvant Announces ARU-2801 Data Oral Presentation at Society for Endocrinology BES 2021 Conference

Tuesday, October 26, 2021 - 2:00pm

NEW YORK and BASEL, Switzerland, Oct. 26, 2021 /PRNewswire/ -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, announced an oral presentation at the Society for Endocrinology BES 2021 conference in Edinburgh, Scotland.

Key Points: 
  • NEW YORK and BASEL, Switzerland, Oct. 26, 2021 /PRNewswire/ -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, announced an oral presentation at the Society for Endocrinology BES 2021 conference in Edinburgh, Scotland.
  • "The data being presented at SfE BES 2021 support the development of ARU-2801 as a new, one-time treatment option for patients with HPP," said Will Chou, M.D., chief executive officer of Aruvant.
  • This data suggests that using ARU-2801, an AAV gene therapy, may provide durable clinical benefit to HPP patients after a single injection.
  • Preliminary clinical data demonstrate engraftment of ARU-1801 and amelioration of SCD is possible with one dose of reduced intensity chemotherapy.

Hudson Pacific Properties Earns Top Recognition in 2021 GRESB Assessment for ESG Leadership

Monday, October 25, 2021 - 2:00pm

Hudson Pacific Properties, Inc. (NYSE: HPP) today announced that it has earned top honors in the 2021 Global Real Estate Sustainability Benchmark (GRESB) Real Estate Assessment for its ESG accomplishments.

Key Points: 
  • Hudson Pacific Properties, Inc. (NYSE: HPP) today announced that it has earned top honors in the 2021 Global Real Estate Sustainability Benchmark (GRESB) Real Estate Assessment for its ESG accomplishments.
  • We are incredibly proud to be recognized by GRESB as an ESG leader in our industry, said Victor Coleman, Chairman and CEO of Hudson Pacific.
  • Hudson Pacific has been widely recognized for its industry leadership in sustainability.
  • The 2021 GRESB recognitions reflect Hudson Pacifics commitmentfrom our Board of Directors to frontline employeesto leadership in sustainability, said Natalie Teear, Senior Vice President of Innovation, Sustainability and Social Impact at Hudson Pacific.